Dr. Carl Berke is a Co-Founder and serves as Board Member & Managing Director at Mass Medical Angels. He is a Co-Founder of Starlight Cardiovascular. He served as Board Observer at Sebacia. He also serves as a Partner at Mass General Brigham Ventures. He serves as Board Member at Pykus Therapeutics and SeQure DX. His career has spanned over 25 years in the practice and management of innovation to bring new technologies from the lab to the market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets - he is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a consulting firm, focusing on the management of innovation and growth strategy for clients in healthcare and consumer products. He has also been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa [research literature management software], Kasalis [robotics], Combinent [women's health], Infobionic [cardiac monitoring], and the Sudanese Education Fund [philanthropy]. He holds an AB degree from Cornell University and received his Ph.D. in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as a Lecturer in the Biomedical Enterprise Program in the Harvard-MIT Division of Health Sciences and Technology. He currently represents the Fund on the Boards of Annovation and Sebacia.